Yes it is, you should also be aware that this company is perilously close to insolvency,(although they have a great product line) which is why it is priced where it is. The only apparent way out is massive dilution, hence the AS has been raised to 1 billion shares. Management has announced that the AS rise is simply a loan condition, and that they plan to pay the usurious loan terms (35k per month due beginning 5/4 on the first 200k tranche alone with the possibility of other concurrent subsequent payments in the same monthly amounts )off in cash. Management has no outlined where the cash will come from, other than to say they have cut labor and presumably other expenses. Ask yourself what percentage of 1.2 quarterly revenue went to labor. Labor was supposedly cut by 57%. If they went from lets say 7 staff to 3 at an average salary and benefits of 35 k per year, that's 140k per year or 35 k per quarter. That amount equals one month's payment per quarter leaving another 70k to be paid out of revenues, which were falling as of last quarter.
I don't doubt that the company is on a path to good profitability, I just doubt that they are there yet and have any possible way to avoid dilution. The CEO has yet to come clean with the facts, notwithstanding his open letter to shareholders, in which he promised to provide more information to investors.
News 
Market Data 
Discover 
